Literature DB >> 11091848

Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

G Niedobitek1.   

Abstract

The association of nasopharyngeal carcinoma (NPC) with the Epstein-Barr virus (EBV) was firmly established as early as 1973. Nevertheless, the role for the virus in the pathogenesis of NPC is still controversial. In this article, the evidence implicating EBV in the development of NPC is reviewed, focusing on the cellular site of EBV persistence, the association of the virus with different NPC histotypes, the tumour cell phenotype in the context of viral latent gene expression, and the possible role of the lymphoid stroma.

Entities:  

Mesh：

Year:  2000        PMID： 11091848      PMCID： PMC1186977          DOI： 10.1136/mp.53.5.248

Source DB:  PubMed          Journal:  Mol Pathol        ISSN： 1366-8714


  90 in total

1.  Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation.

Authors:  F Sbih-Lammali; B Clausse; H Ardila-Osorio; R Guerry; M Talbot; S Havouis; L Ferradini; J Bosq; T Tursz; P Busson
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

2.  Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.

Authors:  R G Caldwell; J B Wilson; S J Anderson; R Longnecker
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

3.  EBV persistence in memory B cells in vivo.

Authors:  G J Babcock; L L Decker; M Volk; D A Thorley-Lawson
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

4.  Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.

Authors:  J E Floettmann; A G Eliopoulos; M Jones; L S Young; M Rowe
Journal:  Oncogene       Date:  1998-11-05       Impact factor: 9.867

5.  CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus.

Authors:  J D Fingeroth; M E Diamond; D R Sage; J Hayman; J L Yates
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.

Authors:  T Imai; M Nagira; S Takagi; M Kakizaki; M Nishimura; J Wang; P W Gray; K Matsushima; O Yoshie
Journal:  Int Immunol       Date:  1999-01       Impact factor: 4.823

7.  Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells.

Authors:  Y T Huang; T S Sheen; C L Chen; J Lu; Y Chang; J Y Chen; C H Tsai
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

8.  Staining of interleukin-10 predicts clinical outcome in patients with nasopharyngeal carcinoma.

Authors:  S Fujieda; K Lee; H Sunaga; H Tsuzuki; H Ikawa; G K Fan; M Imanaka; H Takenaka; H Saito
Journal:  Cancer       Date:  1999-04-01       Impact factor: 6.860

9.  Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

Authors:  C M Rooney; C A Smith; C Y Ng; S K Loftin; J W Sixbey; Y Gan; D K Srivastava; L C Bowman; R A Krance; M K Brenner; H E Heslop
Journal:  Blood       Date:  1998-09-01       Impact factor: 22.113

10.  Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses.

Authors:  M T Bejarano; M G Masucci
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113
View more
  49 in total

1.  Themed issue: the biology and pathology of the Epstein-Barr virus.

Authors:  P G Murray; L S Young
Journal:  Mol Pathol       Date:  2000-10

2.  Serologic biomarkers of Epstein-Barr virus correlate with TNM classification according to the seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma.

Authors:  Peng Sun; Cui Chen; Yi-Kan Cheng; Zhi-Jian Zeng; Xin-Lin Chen; Li-Zhi Liu; Mo-Fa Gu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-09       Impact factor: 2.503

3.  Fingerprints of Epstein-Barr virus in nasopharyngeal carcinoma.

Authors:  Robert B West
Journal:  Nat Genet       Date:  2014-08       Impact factor: 38.330

4.  Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia.

Authors:  Servi J C Stevens; Sandra A W M Verkuijlen; Bambang Hariwiyanto; Jajah Fachiroh; Dewi K Paramita; I Bing Tan; Sophia M Haryana; Jaap M Middeldorp
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Nasopharyngeal carcinoma: recognizing the radiographic features in children.

Authors:  Hilda E Stambuk; Snehal G Patel; Kristine M Mosier; Suzanne L Wolden; Andrei I Holodny
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

6.  Molecular diagnosis in head and neck: what a surgical pathologist must know.

Authors:  Jennifer L Hunt
Journal:  Head Neck Pathol       Date:  2008-02-26

7.  Immunohistochemical expression of latent membrane protein 1 (LMP1) and p53 in nasopharyngeal carcinoma: Moroccan experience.

Authors:  I Tabyaoui; Z Serhier; S Sahraoui; S Sayd; R Cadi; O M Bennani; A Benider; S Zamiati; Jouti N Tahiri
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

8.  Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients.

Authors:  Zhixiong Lin; Brian Khong; Shirley Kwok; Hongbin Cao; Robert B West; Quynh-Thu Le; Christina S Kong
Journal:  Head Neck       Date:  2013-10-26       Impact factor: 3.147

9.  Gender-specific associations between MICA-STR and nasopharyngeal carcinoma in a southern Chinese Han population.

Authors:  Wei Tian; Xiao-Min Zeng; Li-Xin Li; He-Kun Jin; Qi-Zhi Luo; Fan Wang; Shi-Shi Guo; Ya Cao
Journal:  Immunogenetics       Date:  2006-03-18       Impact factor: 2.846

10.  SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma.

Authors:  Yuan-Jiao Huang; Chao Xuan; Bei-Bei Zhang; Ming Liao; Kai-Feng Deng; Min He; Jin-Min Zhao
Journal:  J Exp Clin Cancer Res       Date:  2009-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.